NuvaRing investigation: Google map
Posted by hannahflynn on February 11, 2010
Above is a map showing the results, so far, of my investigation into the availability of the NuvaRing in England, by Primary Care Trust (PCT).
- Red signifies a PCT where the NuvaRing is not available.
- Yellow signifies a PCT where the NuvaRing is available with restrictions.
- Green signifies a PCT where the NuvaRing is available.
The responses are available where appropriate for you to peruse.
It has become clear during this investigation so far, the NuvaRing is still being considered for inclusion in many areas. Some can give no time frame for when a decision will be made and many do not expect a decision to be made for many months.
The reasons given for this are varied. They include a lack of information regarding where funding will come from and very frequently, a lack of demand for the product. In the case of Trafford PCT, the drug has been clinically approved but ‘financial concerns have not been resolved’.
Cost concerns arise again, even where the NuvaRing is available. Nearby Manchester PCT warned, ‘ We advocate principles of cost effectiveness and where applicable this may mean using the drug of the lowest acquisition cost.’
Although some PCTs cite a lack of demand for the NuvaRing (for example in Redbridge and South Staffordshire PCTs no application had been made for the NuvaRing), South and Eastern Kent PCT reports 60 being prescribed in the last financial year (the NuvaRing became available in January 2009).
I await further information to add to this investigation.